Laura Lee Sandler
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 15SEC | ORKAOruka Therapeutics, Inc. | Sell | 906235,478 held (−0%) | $95.71 | $87K | -14.2% |
| Sep 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 1,000240,384 held (−0%) | $91.05 | $91K | -9.8% |
| Sep 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 4,000236,384 held (−2%) | $92.01 | $368K | -10.8% |
| Jul 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,237239,147 held (−1%) | $93.85 | $210K | -12.5% |
| Jul 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,263236,884 held (−1%) | $94.75 | $214K | -13.3% |
| Jul 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 500236,384 held (−0%) | $95.47 | $48K | -14.0% |
| Jun 15SEC | ORKAOruka Therapeutics, Inc. | Sell | 600236,384 held (−0%) | $69.69 | $42K | +17.8% |
| May 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,200239,784 held (−1%) | $62.58 | $138K | +31.2% |
| May 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 1,800237,984 held (−1%) | $64.15 | $115K | +28.0% |
| May 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 300237,684 held (−0%) | $65.10 | $20K | +26.1% |
| May 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 400237,284 held (−0%) | $66.06 | $26K | +24.3% |
| May 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 200237,084 held (−0%) | $67.16 | $13K | +22.3% |
| May 1SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 100236,984 held (−0%) | $68.48 | $7K | +19.9% |
| Mar 17SEC | ORKAOruka Therapeutics, Inc. | Sell | 600236,984 held (−0%) | $41.30 | $25K | +98.8% |
| Mar 2SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,325240,259 held (−1%) | $33.28 | $77K | +146.7% |
| Mar 2SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,675237,584 held (−1%) | $33.81 | $90K | +142.9% |
| Jan 2SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 8,748209,336 held (−4%) | $28.17 | $246K | +191.5% |
| Jan 2SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 3,144206,192 held (−2%) | $29.08 | $91K | +182.4% |
| Jan 2SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 1,108205,084 held (−1%) | $29.75 | $33K | +176.0% |
- Sell
COO Laura Lee Sandler sold $91K of ORKA at $91.05 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Laura Lee Sandler sold $368K of ORKA at $92.01 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Laura Lee Sandler sold $210K of ORKA at $93.85 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Laura Lee Sandler sold $214K of ORKA at $94.75 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Laura Lee Sandler sold $48K of ORKA at $95.47 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Laura Lee Sandler sold $138K of ORKA at $62.58 — pre-scheduled 10b5-1 plan sale.